TPG's Rise Fund has made a strategic minority investment in Healthcademia to support its growth in the healthcare education sector across Europe and the Americas.
Information on the Target
Healthcademia is a premier global entity in healthcare education, actively operating in 11 countries. The organization is renowned for its dedication to providing high-quality educational experiences and measurable outcomes in higher education, including exceptional test preparation and specialized professional training programs. With a robust presence in key European markets such as Spain, France, Italy, and the UK, as well as in Latin America, Healthcademia continues to establish itself as a benchmark in healthcare education.
Founded in 2006, Healthcademia boasts an impressive alumni network of over 120,000 healthcare professionals who have benefited from its diverse training programs. The institution is committed to facilitating lifelong learning opportunities across various specialties, leveraging advanced technology and up-to-date methodologies to enhance the relevance and adaptability of its graduates in the evolving healthcare landscape.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The healthcare education industry has witnessed significant growth in Europe, particularly due to increasing demands for skilled healthcare professionals stemming from aging populations and rising chronic diseases. Educat
Similar Deals
Mustard Seed + Partners, Jacobs Holding AG → ILERNA
2024
Bregal Milestone → Odilo
2023
Oryon Universal → Growth Road
TPG
invested in
Healthcademia
in 2025
in a Growth Equity & Expansion Capital deal